Eye Care - Qatar

  • Qatar
  • Revenue in the Eye Care market amounts to US$1.92m in 2024. The market is expected to grow annually by 2.85% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$1,256m in 2024).
  • In relation to total population figures, per person revenues of US$0.70 are generated in 2024.

Key regions: Canada, Thailand, Philippines, Worldwide, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Eye Care market in Qatar has been experiencing significant growth in recent years. Customer preferences are shifting towards more advanced and specialized eye care services, leading to the introduction of new technologies and treatments in the market.

Additionally, local special circumstances and underlying macroeconomic factors have also contributed to the development of the Eye Care market in Qatar. Customer preferences in the Eye Care market in Qatar are evolving, with a growing demand for advanced and specialized services. Qatar has a high prevalence of eye diseases and disorders, such as cataracts and glaucoma, which has led to an increased need for specialized eye care services.

Customers are seeking out clinics and hospitals that offer the latest technologies and treatments to address their specific eye health needs. This trend is driving the growth of innovative eye care solutions in the market, including laser eye surgery, advanced diagnostic tools, and specialized treatments for various eye conditions. Trends in the Eye Care market in Qatar are centered around the adoption of new technologies and treatments.

There has been a significant increase in the number of eye care clinics and hospitals offering laser eye surgery, which provides a safe and effective alternative to traditional vision correction methods. Additionally, there is a growing focus on preventive eye care, with more clinics offering comprehensive eye exams and screenings to detect and address eye health issues at an early stage. This trend is driven by the increasing awareness among customers about the importance of regular eye check-ups and the potential risks associated with untreated eye conditions.

Local special circumstances in Qatar have also contributed to the development of the Eye Care market. The country has a high prevalence of diabetes, which is a major risk factor for eye diseases such as diabetic retinopathy. This has created a need for specialized eye care services that can effectively manage and treat diabetic eye conditions.

Qatar's growing population, particularly among the elderly, has also increased the demand for eye care services, as age-related eye conditions become more prevalent. Underlying macroeconomic factors have played a role in the development of the Eye Care market in Qatar. The country's strong economy and high per capita income have enabled individuals to invest in their health, including eye care.

Additionally, Qatar's commitment to healthcare infrastructure development has resulted in the establishment of world-class eye care facilities and the recruitment of skilled ophthalmologists and eye care professionals. These factors have contributed to the growth and expansion of the Eye Care market in Qatar. In conclusion, the Eye Care market in Qatar is experiencing significant growth driven by evolving customer preferences, the adoption of new technologies and treatments, local special circumstances, and underlying macroeconomic factors.

The market is expected to continue to develop as the demand for specialized eye care services increases and as advancements in technology and treatments continue to emerge.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)